Hap Trading, LLC Iveric Bio, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $3.02 Million - $4.2 Million	-175,400 Reduced 76.9%	52,700 $15,000
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $2.14 Million - $4.24 Million	228,100 New	228,100 $328,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $815,970 - $1.11 Million	-59,000 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$7.07 - $17.5 $417,130 - $1.03 Million	59,000 New	59,000 $243,000
Q1 2021 May 14, 2021	SELL	$5.08 - $6.89 $71,120 - $96,460	-14,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.65 - $7.66 $15,255 - $20,682	-2,700 Reduced 16.17%	14,000 $13,000
Q3 2020 Nov 13, 2020	BUY	$4.01 - $6.29 $66,967 - $105,043	16,700 New	16,700 $14,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.